The University of Chicago Header Logo

Connection

S. Margaret Paik to Doxorubicin

Back to Details
This is a "connection" page, showing publications S. Margaret Paik has written about Doxorubicin.
S. Margaret Paik
Connection Strength
0.036
Doxorubicin
  1. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2. J Clin Oncol. 2020 02 10; 38(5):444-453.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.